Jasminka Sterjovski

1.4k total citations
33 papers, 1.1k citations indexed

About

Jasminka Sterjovski is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jasminka Sterjovski has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Virology, 19 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Jasminka Sterjovski's work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (14 papers). Jasminka Sterjovski is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (14 papers). Jasminka Sterjovski collaborates with scholars based in Australia, United States and Sweden. Jasminka Sterjovski's co-authors include Paul R. Gorry, Melissa J. Churchill, Steve Wesselingh, Lachlan Gray, Paul A. Ramsland, Michael Roche, Anne Ellett, Anthony L. Cunningham, Benhur Lee and Sharon R. Lewin and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Journal of Virology.

In The Last Decade

Jasminka Sterjovski

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasminka Sterjovski Australia 21 882 509 373 272 168 33 1.1k
Silvia Ratto‐Kim United States 22 961 1.1× 469 0.9× 571 1.5× 286 1.1× 344 2.0× 56 1.4k
Verónica Briz Spain 18 537 0.6× 576 1.1× 123 0.3× 211 0.8× 203 1.2× 65 977
Egidio Brocca‐Cofano United States 22 587 0.7× 227 0.4× 529 1.4× 244 0.9× 258 1.5× 37 1.0k
Benjamin Lepene United States 17 156 0.2× 317 0.6× 175 0.5× 469 1.7× 99 0.6× 27 850
Sushama Telwatte United States 15 481 0.5× 354 0.7× 173 0.5× 179 0.7× 116 0.7× 26 703
Fiona Wightman Australia 17 944 1.1× 568 1.1× 490 1.3× 247 0.9× 326 1.9× 24 1.3k
Anne Ellett Australia 20 1.6k 1.8× 835 1.6× 712 1.9× 341 1.3× 354 2.1× 29 1.8k
Guobin Kang United States 15 443 0.5× 266 0.5× 286 0.8× 137 0.5× 176 1.0× 37 797
Katherine Perkey United States 7 698 0.8× 452 0.9× 290 0.8× 80 0.3× 169 1.0× 9 857
Cecilia Cabrera Spain 21 1.0k 1.2× 669 1.3× 750 2.0× 293 1.1× 337 2.0× 65 1.7k

Countries citing papers authored by Jasminka Sterjovski

Since Specialization
Citations

This map shows the geographic impact of Jasminka Sterjovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasminka Sterjovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasminka Sterjovski more than expected).

Fields of papers citing papers by Jasminka Sterjovski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasminka Sterjovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasminka Sterjovski. The network helps show where Jasminka Sterjovski may publish in the future.

Co-authorship network of co-authors of Jasminka Sterjovski

This figure shows the co-authorship network connecting the top 25 collaborators of Jasminka Sterjovski. A scholar is included among the top collaborators of Jasminka Sterjovski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasminka Sterjovski. Jasminka Sterjovski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flynn, Jacqueline K., Paula Ellenberg, Renee C. Duncan, et al.. (2017). Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists. AIDS Research and Human Retroviruses. 33(12). 1220–1235. 6 indexed citations
2.
3.
Liu, Xuyu, Lara R. Malins, Michael Roche, et al.. (2014). Site-Selective Solid-Phase Synthesis of a CCR5 Sulfopeptide Library To Interrogate HIV Binding and Entry. ACS Chemical Biology. 9(9). 2074–2081. 24 indexed citations
4.
Roche, Michael, Hamid Salimi, Renee C. Duncan, et al.. (2013). A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations. Retrovirology. 10(1). 43–43. 54 indexed citations
5.
Jakobsen, Martin R., Jasminka Sterjovski, Michael Roche, et al.. (2013). Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitrousage of alternative coreceptors during progressive HIV-1 subtype C infection. Retrovirology. 10(1). 98–98. 19 indexed citations
6.
Gray, Lachlan, et al.. (2013). CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm. Retrovirology. 10(1). 24–24. 24 indexed citations
7.
Gray, Lachlan, Jasminka Sterjovski, Paul A. Ramsland, Melissa J. Churchill, & Paul R. Gorry. (2011). Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues. Retrovirology. 8(1). 42–42. 8 indexed citations
8.
Telwatte, Sushama, Adam Johnson, David Tyssen, et al.. (2011). Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. Antiviral Research. 90(3). 195–199. 79 indexed citations
9.
Roche, Michael, Martin R. Jakobsen, Jasminka Sterjovski, et al.. (2011). HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism. Journal of Virology. 85(9). 4330–4342. 66 indexed citations
10.
Repits, Johanna, Jasminka Sterjovski, Hannes Uchtenhagen, et al.. (2011). Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge. PLoS ONE. 6(6). e20135–e20135. 27 indexed citations
11.
Sterjovski, Jasminka, Lachlan Gray, Michael Roche, et al.. (2009). Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection. Virology. 396(2). 246–255. 18 indexed citations
12.
Gray, Lachlan, Michael Roche, Melissa J. Churchill, et al.. (2009). Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain. Journal of Virology. 83(15). 7794–7794. 1 indexed citations
13.
Repits, Johanna, Jasminka Sterjovski, Melissa J. Churchill, et al.. (2008). Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression. Retrovirology. 5(1). 28–28. 21 indexed citations
14.
Repits, Johanna, Jasminka Sterjovski, Mattias Mild, et al.. (2008). Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. Virology. 379(1). 125–134. 36 indexed citations
15.
Sterjovski, Jasminka, Melissa J. Churchill, Anne Ellett, et al.. (2007). Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology. 4(1). 89–89. 73 indexed citations
16.
Gray, Lachlan, Melissa J. Churchill, Jasminka Sterjovski, et al.. (2007). Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source. Virology Journal. 4(1). 75–75. 16 indexed citations
17.
Gray, Lachlan, Melissa J. Churchill, Niamh M. Keane, et al.. (2006). Genetic and Functional Analysis of R5X4 Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Derived from Two Individuals Homozygous for the CCR5Δ32 Allele. Journal of Virology. 80(7). 3684–3691. 41 indexed citations
18.
19.
Thompson, Katherine A., Melissa J. Churchill, Paul R. Gorry, et al.. (2004). Astrocyte specific viral strains in HIV dementia. Annals of Neurology. 56(6). 873–877. 67 indexed citations
20.
Churchill, Melissa J., Jasminka Sterjovski, Lachlan Gray, et al.. (2004). Longitudinal Analysis ofnef/Long Terminal Repeat–Deleted HIV‐1 in Blood and Cerebrospinal Fluid of a Long‐Term Survivor Who Developed HIV‐Associated Dementia. The Journal of Infectious Diseases. 190(12). 2181–2186. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Ratto‐Kim Breakdown of academic impact, for papers by Verónica Briz Breakdown of academic impact, for papers by Egidio Brocca‐Cofano Breakdown of academic impact, for papers by Benjamin Lepene Breakdown of academic impact, for papers by Sushama Telwatte Breakdown of academic impact, for papers by Fiona Wightman Breakdown of academic impact, for papers by Anne Ellett Breakdown of academic impact, for papers by Guobin Kang Breakdown of academic impact, for papers by Katherine Perkey Breakdown of academic impact, for papers by Cecilia Cabrera
Rankless by CCL
2026